Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Optical Coherence Tomography in Multiple Sclerosis.
Rebif approval application
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Differential transcriptional response profiles in human myeloid cell populations.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
Biomarkers of disease activity in multiple sclerosis.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Clinically isolated syndromes.
A monoclonal natural human IgM protects axons in the absence of remyelination.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
FDA product review for daclizumab
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Sex hormones and multiple sclerosis: another informative failure.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Dimethylfumarate induces apoptosis in human mast cells.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Pages
« first
‹ previous
…
34
35
36
37
38
39
40
41
42
…
next ›
last »